Page last updated: 2024-08-21

carvacrol and Leishmaniasis

carvacrol has been researched along with Leishmaniasis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Andrade-Neto, VV; Chandasana, H; Costa, AMB; Derendorf, H; Dolabella, S; Galvão, JG; Kima, PE; Lira, AAM; Nunes, RS; Santos, JS; Santos, RL; Scher, R; Silva, ARST; Torres-Santos, EC1

Other Studies

1 other study(ies) available for carvacrol and Leishmaniasis

ArticleYear
Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2020, Jul-01, Volume: 150

    Topics: Animals; Antiprotozoal Agents; Cell Survival; Cymenes; Drug Carriers; Drug Liberation; Humans; Leishmania; Leishmaniasis; Lipids; Macrophages, Peritoneal; Male; Mice, Inbred BALB C; Nanostructures; Rats, Wistar; THP-1 Cells

2020